Jump Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jump Trading’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,194	Closed	-$33K	–	474
2017 Q4	$33K	Buy	+1,194	New	+$37.1K	﹤0.01%	365

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Jump Trading's AVEO Position: Q1 2018 in Review

Jump Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2018, closing a stake of 1,194 shares — an estimated $33K sold.

Jump Trading first reported a position in AVEO in Q4 2017 and held it in 1 quarter. The position peaked at $33K in Q4 2017. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.

Jump Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Jump Trading sold 1,194 AVEO Pharmaceuticals, Inc. shares in Q1 2018, an estimated $33K.
Jump Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
Jump Trading's AVEO Pharmaceuticals, Inc. position peaked at $33K in Q4 2017.
90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2018.

Based on Jump Trading's 13F filing for Q1 2018, filed 11 May 2018.